Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Pharmacyclics Inc (PCYC)    
$104.50 0.58 (0.56%) as of 4:30 Thu 7/24


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 73,583,000 as of 6/30
Market Cap: 7.69(B)
Last Volume: 1,042,193 Avg Vol: 842,111
52 Week Range: $85.85 - $151.61
Level I Sector: Health Care
Level II Sector:   Drugs
Level III Sector:      Drug Manufacturers - Other

Member Indexes:

    NASDAQ BIOTECHNOLOGY       NASDAQ COMPOSITE  
    NASDAQ NNM COMPOSITE  

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
 

Company Profile   Pharmacyclics is a biopharmaceutical company focused on developing and commercializing small-molecule drugs for the treatment of cancer and immune mediated diseases. Co. has three proprietary drug candidates under clinical development and several preclinical lead molecules: an inhibitor of Bruton's tyrosine kinase (BTK) ibrutinib in several Phase III studies in hematologic malignancies, a BTK inhibitor lead optimization program targeting anti-inflammatory and autoimmune indications, an inhibitor of Factor VIIa in a Phase II clinical trial in pancreatic cancer and a histone deacetylase inhibitor, abexinostat, in Phase I and II clinical trials in solid tumors and hematological malignancies.

 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 144,370 243,370 648,406
Total Sell Value $0 $20,657,003 $31,142,530 $58,598,648
Total People Sold 0 7 10 14
Total Sell Transactions 0 10 16 39
End Date 2014-04-24 2014-01-21 2013-07-23 2012-07-23

   
Records found: 343
  Page 1 of 14  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Soni Manmeet Singh Chief Financial Officer   •       –      –    2014-07-22 4 A $0.00 $0 D/D 6,000 38,610     -
   Sjovall Boultbee Paula S EVP, Sales and Marketing   •       –      –    2014-05-08 4 OE $25.94 $199,997 D/D 7,710 9,653     -
   Outten Matthew VP, Commercial Operations   •       –      –    2014-04-30 4 A $80.39 $16,400 D/D 204 10,758     -
   Sjovall Boultbee Paula S EVP, Sales and Marketing   •       –      –    2014-04-30 4 A $80.39 $16,400 D/D 204 1,943     -
   Sjovall Boultbee Paula S EVP, Sales and Marketing   •       –      –    2014-04-30 4 A $80.39 $16,400 I/I 204 2,932     -
   Erdtmann Rainer M Sr. VP, IR and Admin   •       –      –    2014-04-30 4 A $80.39 $16,400 D/D 204 5,701     -
   Soni Manmeet Singh Chief Financial Officer   •       –      –    2014-04-30 4 A $80.39 $16,400 D/D 204 32,610     -
   Zanganeh Maky Chief Operating Officer   •       –      –    2014-04-30 4 A $80.39 $16,400 D/D 204 210,311     -
   Tan Heow Chief Quality&Tech Operations   •       –      –    2014-04-30 4 A $80.39 $16,400 D/D 204 1,873     -
   Love Richard B General Counsel   •       –      –    2014-04-30 4 A $80.39 $16,400 D/D 204 204     -
   Fardis Maria Chief of Oncology Ops & Allian   •       –      –    2014-04-30 4 A $80.39 $16,400 D/D 204 3,192     -
   Sjovall Boultbee Paula S EVP, Sales and Marketing   •       –      –    2014-04-29 4 OE $57.16 $133,297 I/I 2,332 2,728     -
   Outten Matthew VP, Commercial OperationsOffic   •       –      –    2014-03-10 3 IO $0.00 $0 D/D 0 10,554 -21%     
   Outten Matthew VP, Commercial OperationsOffic   •       –      –    2014-03-10 3 IO $0.00 $0 I/I 0 180 -21%     
   Sjovall Boultbee Paula S EVP, Sales and Marketing   •       –      –    2014-03-05 4 S $140.75 $880,115 D/D (6,253) 1,739 26%     
   Mcgreivy Jesse Chief Medical Officer   •       –      –    2014-03-05 4 OE $25.33 $166,241 D/D 6,563 6,563     -
   Mcgreivy Jesse Chief Medical Officer   •       –      –    2014-03-05 4 S $139.66 $916,599 D/D (6,563) 0 26%     
   Hemmi Gregory Sr. VP Chemical Operations   •       –      –    2014-03-05 4 OE $0.86 $12,900 D/D 15,000 53,004     -
   Hemmi Gregory Sr. VP Chemical Operations   •       –      –    2014-03-05 4 S $140.00 $2,100,033 D/D (15,000) 38,004 26%     
   Fardis Maria Chief of Oncology Ops & Allian   •       –      –    2014-03-05 4 OE $6.84 $20,520 D/D 3,000 5,988     -
   Fardis Maria Chief of Oncology Ops & Allian   •       –      –    2014-03-05 4 S $140.50 $421,504 D/D (3,000) 2,988 26%     
   Sjovall Boultbee Paula S EVP, Sales and Marketing   •       –      –    2014-03-05 4 OE $25.94 $162,203 D/D 6,253 7,992     -
   Chang Betty Y VP, Research/Biology   •       –      –    2014-03-04 4 OE $7.69 $179,238 D/D 17,500 21,254     -
   Chang Betty Y VP, Research/Biology   •       –      –    2014-03-04 4 S $137.97 $2,414,484 D/D (17,500) 3,754 24%     
   Halvorson Eric H Director   –       •      –    2014-03-04 4 OE $14.26 $61,332 D/D 3,472 4,472     -

  343 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 14
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed